Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
FDA Press Release on First Treatment for Menkes Disease Rare Disease: FDA Expands Treatment Approval for Gaucher Disease The FDA expanded the approval of Sanofis Cerezyme (imiglucerase) intravenous infusion enzyme replacement therapy to treat non-neurological symptoms in patients with Type 3 Gaucher disease, which is the rarest and most serious type
Similarly, there is no evidence that multiple doses of activated charcoal do increase the elimination of VPA or toxic metabolites
Eur J Med Res 29(1):237
The blue to blue-green appearance is associated with copper coordination
US$ 26.80
US$ 25.28
US$ 20.96
US$ 21.45
